Traders sold shares of UnitedHealth Group (NYSE:UNH) on strength during trading on Wednesday. $83.82 million flowed into the stock on the tick-up and $145.51 million flowed out of the stock on the tick-down, for a money net flow of $61.69 million out of the stock. Of all companies tracked, UnitedHealth Group had the 16th highest net out-flow for the day. UnitedHealth Group traded up $2.22 for the day and closed at $241.72
UNH has been the topic of several recent analyst reports. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Thursday, April 19th. Piper Jaffray restated a “buy” rating and set a $270.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 18th. Credit Suisse Group raised their price objective on UnitedHealth Group from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, April 18th. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 18th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $253.70.
Get UnitedHealth Group alerts:
The company has a debt-to-equity ratio of 0.56, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market cap of $233.42 billion, a price-to-earnings ratio of 24.00, a price-to-earnings-growth ratio of 1.40 and a beta of 0.75.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.13. The firm had revenue of $55.19 billion for the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The firm’s revenue for the quarter was up 13.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.37 EPS. sell-side analysts predict that UnitedHealth Group will post 12.61 earnings per share for the current year.
In other news, CEO Steven H. Nelson sold 14,233 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $230.22, for a total value of $3,276,721.26. Following the sale, the chief executive officer now owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 10,400 shares of the business’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $229.87, for a total value of $2,390,648.00. Following the completion of the sale, the director now directly owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The disclosure for this sale can be found here. Insiders have sold a total of 72,019 shares of company stock worth $16,550,733 in the last ninety days. 0.87% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently bought and sold shares of UNH. Exane Derivatives raised its stake in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares in the last quarter. Aevitas Wealth Management Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $102,000. Bamco Inc. NY bought a new stake in shares of UnitedHealth Group in the 1st quarter worth $117,000. Pathstone Family Office LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $129,000. Finally, Trustcore Financial Services LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $133,000. 87.11% of the stock is currently owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.